Dr. Brian L. Parkin, MD

Dr. Parkin practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Parkin's NPI, 1568582393, was assigned on March 29, 2007. Dr. Parkin graduated from University of Toledo College of Medicine and Life Sciences in 2004. Dr. Parkin holds Florida license 152427.

Dr. Parkin's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Parkin's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Parkin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parkin practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Parkin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Parkin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Parkin's licenses on file in 2 states: Florida and Michigan.

CMS data shows 159 Medicare services from Dr. Parkin across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $15,252 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Parkin in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parkin's median patient age at 65, with 42% women.

Dr. Parkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Parkin, published from 2010 to 2022. 2015 was the busiest year, with 4. The most frequent topics are Leukemia, Myeloid, Acute, Cell Line, Tumor and fms-Like Tyrosine Kinase 3. Dr. Parkin has published most often in Blood. Dr. Parkin's most frequent co-authors are Sami Nimer Malek, MD, John Martin Magenau, MD and Mary Mansour Riwes, DO.

Dmand AI links Dr. Parkin to 8 clinical trials, 4 of them phase 1 studies. 6 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Leukemia. Syndax Pharmaceuticals sponsors the most, 2.

CMS Open Payments shows 65 general payments to Dr. Parkin from 22 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. Daiichi Sankyo Inc. paid the most, $10,926.

Dr. Parkin graduated from University of Toledo College of Medicine and Life Sciences in 2004.

Dr. Parkin is in network with 7 carriers, including Cigna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.